Jennifer Schöning

935 citations
11 papers · 464 indexed · h-index 9
Topics
Histone Deacetylase Inhibitors Research (2 papers)MicroRNA in disease regulation (2 papers)Protein Degradation and Inhibitors (2 papers)

In The Last Decade

Jennifer Schöning

11 papers receiving 461 citations

Peers

Jennifer Schöning
Comparison fields: 5 of 72
  • Molecular Biology 262
  • Cancer Research 198
  • Immunology 115
  • Oncology 102
  • Epidemiology 42
Replace Alberto Cedro‐Tanda with:
Alberto Cedro‐Tanda Mexico
Noraini Abd-Aziz Malaysia
Hongbing Ni China
Rossella Fasano Italy
Pramod S. Gowda United States
Ensieh Farahani Denmark
Robert Valentine United Kingdom
Dona N. Ho Hong Kong
Divya Iyer United States
Jennifer Schöning relative to Alberto Cedro‐Tanda Mexico Alberto Cedro‐Tanda's profile →
Citations per field
00.5×8.7×
Alberto Cedro‐Tanda · 1×
Citations per year

Countries citing papers authored by Jennifer Schöning

Since Specialization
Citations

This map shows the geographic impact of Jennifer Schöning's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jennifer Schöning with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jennifer Schöning more than expected).

Fields of papers citing papers by Jennifer Schöning

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jennifer Schöning. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jennifer Schöning. The network helps show where Jennifer Schöning may publish in the future.

Co-authorship network of co-authors of Jennifer Schöning

This figure shows the co-authorship network connecting the top 25 collaborators of Jennifer Schöning. A scholar is included among the top collaborators of Jennifer Schöning based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jennifer Schöning. Jennifer Schöning is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
#WorkIndexed citations
1 42
2 37
3 54
4 26
5 15
6 11
7 102
8 49
9 122
10 5
11 1

About Jennifer Schöning

Jennifer Schöning is a scholar working on Pharmaceutical Science, Cancer Research and Microbiology, having authored 11 papers that have together received 464 indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (2 papers), MicroRNA in disease regulation (2 papers) and Protein Degradation and Inhibitors (2 papers). The work is most often cited by research in Cancer Research (198 citations), Immunology (115 citations) and Molecular Biology (262 citations). Jennifer Schöning has collaborated with scholars based in Germany, Australia and United States. Frequent co-authors include Wenyi Gu, Michael J. Monteiro, Stephan Emmrich, Jan‐Henning Klusmann, Dirk Reinhardt, Axel Schambach, Zhe Li, Christina Reimer, Ying Xie and Mareike Rasche. Their work appears in journals such as Proceedings of the National Academy of Sciences, Genes & Development and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026